A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-00422-2
Abstract: Cisplatin (ddp), which is commonly employed in the treatment of many advanced cancers, often results in initial therapeutic success; however, rapid progression of ddp-resistant cells remains the main reason for treatment failure. Facd with such… read more here.
Keywords: resistant cells; ddp; treatment; cisplatin ... See more keywords
Abstract 428: Low cellular pH promotes survival in CDK4/6 inhibitor resistant ER+ breast cancer
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-428
Abstract: Cyclin dependent kinase 4 and 6 inhibitors (CDK4/6i) are part of standard of care therapy in combination with antiestrogens for the treatment of metastatic estrogen receptor positive (ER+) breast cancer. However, resistance to CDK4/6i is… read more here.
Keywords: sensitive cells; cancer; breast cancer; breast ... See more keywords
Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0225290
Abstract: Purpose Chemotherapy resistance of esophageal cancer is a key factor affecting the postoperative treatment of esophageal cancer. Among the media that transmit signals between cells, the exosomes secreted by tumor cells mediate information transmission between… read more here.
Keywords: drug; sensitive cells; resistance; esophageal cancer ... See more keywords